We report here on the successful use of functionalized nanohydrogels for the targeted delivery of siRNA against EGFR (epidermal growth factor receptor) in an ovarian cancer mouse model and the consequent inhibition of tumor growth and enhancement of cisplatin chemotherapy. This evidence concerns the gene EGFR and ovarian cancer.